https://carolinaurologicresearchcenter.com/wp-content/uploads/9.11-ESMO-2017-Safety-and-Immunogenicity.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2017-09-11 09:58:372017-09-11 09:58:37ESMO 2017: Safety and Immunogenicity of a DNA-vaccine Immunotherapy in Men with Biochemically (PSA) Relapsed Prostate Cancer
Pfizer and astellas announce positive top line results from phase 3 prosper...